Explainer

Biotechnology Explained

A plain-English guide to biotech – gene editing, mRNA, synthetic biology, and how biological science is transforming medicine, agriculture, and industry.

Key Facts

The first CRISPR gene therapy (Casgevy) was approved in 2023, curing sickle cell disease by editing patients' own cells – a landmark for genetic medicine.

mRNA vaccines were developed in under a year for COVID-19. The same platform is now in trials for cancer, flu, RSV, and rare genetic diseases.

Whole human genome sequencing now costs under $200 and takes hours – down from $2.7 billion and 13 years for the first sequence (2003).

AlphaFold (DeepMind) has predicted the 3D structure of over 200 million proteins – virtually every known protein – accelerating drug discovery worldwide.

GLP-1 receptor agonists (like semaglutide) are transforming the treatment of obesity and diabetes, with potential benefits for heart disease, addiction, and neurodegeneration.

CAR-T cell therapy has achieved complete remission in some patients with previously untreatable blood cancers, with efforts underway to extend it to solid tumours.

Synthetic biology enables microbes to produce spider silk, sustainable aviation fuel, and lab-grown meat proteins – potentially replacing polluting industrial processes.

Antimicrobial resistance is a growing global threat. Biotech approaches – phage therapy, AI-designed antibiotics, rapid diagnostics – may help tackle superbugs.

How Modern Biotech Works

Biology is becoming an engineering discipline. For most of history, we could only observe living systems; now we can read, write, and edit the code of life – DNA – with increasing precision.

Genomics made it possible to read: the Human Genome Project (2003) sequenced all 3.2 billion letters of human DNA. Today, sequencing is ~15 million times cheaper and millions of genomes have been read, revealing the genetic basis of thousands of diseases.

Gene editing – especially CRISPR-Cas9, discovered in 2012 – made it possible to write and edit. CRISPR works like molecular scissors: a guide RNA directs the Cas9 enzyme to a precise location in the genome, where it cuts the DNA. The cell's natural repair machinery then introduces the desired change. Newer tools (base editing, prime editing) are even more precise.

mRNA technology proved its power during the pandemic: synthetic messenger RNA instructs human cells to produce a target protein (like a viral spike protein), training the immune system to fight the real virus. The same platform is now being adapted for personalised cancer vaccines, where mRNA is designed to match the unique mutations in a patient's tumour.

Meanwhile, synthetic biology is engineering entirely new biological systems. Custom-designed microorganisms can produce medicines, sustainable fuels, and novel materials. And AI is accelerating it all – tools like AlphaFold predict protein structures in seconds (a problem that took PhD students years), while machine learning models design new drug candidates faster than any human team.

Biotech Frontiers in 2025–26

Biotechnology is advancing on multiple fronts simultaneously. Key areas to watch:

CRISPR therapies go mainstream

Following the approval of Casgevy (2023) for sickle cell disease, dozens of gene-editing therapies are now in clinical trials for conditions from inherited blindness to high cholesterol.

Personalised cancer vaccines

mRNA vaccines tailored to an individual's tumour mutations are showing promising results in melanoma and pancreatic cancer trials. Moderna and BioNTech are leading this effort.

GLP-1 revolution

Semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) are transforming obesity treatment and showing unexpected benefits for heart disease, kidney disease, and potentially addiction and neurodegeneration.

AI-driven drug discovery

Companies like Isomorphic Labs, Recursion, and Insilico Medicine are using AI to design and test drug candidates, with several AI-discovered drugs now in clinical trials.

Epigenetic editing

New tools that modify gene expression without changing the underlying DNA sequence – potentially offering reversible gene therapy and treatments for diseases of ageing.

Xenotransplantation

Genetically modified pig organs have been transplanted into human patients for the first time, offering hope for the severe shortage of donor organs.

Glossary

Biotechnology

The use of living organisms, cells, or biological systems to develop products and technologies. Modern biotech spans medicine (drugs, diagnostics), agriculture (crop engineering), industry (biofuels, materials), and environmental cleanup.

DNA (deoxyribonucleic acid)

The molecule that carries the genetic instructions for all known living organisms. It consists of two strands twisted into a double helix, with information encoded in sequences of four chemical bases: A, T, C, and G.

RNA (ribonucleic acid)

A single-stranded molecule that plays multiple roles in biology: carrying genetic instructions from DNA (mRNA), building proteins (rRNA, tRNA), and regulating gene activity. mRNA vaccines work by delivering synthetic RNA instructions to cells.

Gene

A segment of DNA that contains the instructions for making a specific protein or functional molecule. Humans have roughly 20,000 protein-coding genes, though gene regulation is far more complex than a simple gene-to-protein mapping.

Genome

The complete set of genetic material in an organism. The human genome contains about 3.2 billion DNA base pairs. The Human Genome Project (completed 2003) first sequenced it; today a whole genome can be sequenced in hours for under $200.

Gene editing

Technologies that allow scientists to precisely alter DNA sequences in living organisms. Unlike older genetic modification methods, modern gene editing (especially CRISPR) can target specific locations in the genome with high accuracy.

CRISPR-Cas9

A revolutionary gene-editing tool adapted from a bacterial immune system. CRISPR uses a guide RNA to direct the Cas9 enzyme to a precise DNA location, where it cuts the strand. The cell's repair mechanisms then introduce the desired change. Won the 2020 Nobel Prize in Chemistry.

Base editing

A newer, more precise form of gene editing that can change individual DNA letters (bases) without cutting both strands of the double helix. This reduces unintended edits and is especially promising for correcting single-letter genetic diseases.

Prime editing

Often called 'search-and-replace' for DNA – a gene-editing technique that can make virtually any small, targeted change to the genome without double-strand breaks. Developed by David Liu's lab at the Broad Institute.

mRNA technology

The platform behind the Pfizer-BioNTech and Moderna COVID-19 vaccines. Synthetic mRNA instructs cells to produce a specific protein (e.g. a viral spike protein), triggering an immune response. Now being developed for cancer vaccines, flu, and rare diseases.

Monoclonal antibodies

Laboratory-made molecules designed to mimic the immune system's ability to target specific proteins. Used to treat cancer, autoimmune diseases, and infections. Drugs like adalimumab (Humira) and trastuzumab (Herceptin) are monoclonal antibodies.

Cell therapy

Treatments that use living cells as medicine. CAR-T cell therapy, for example, engineers a patient's own immune cells to recognise and attack cancer. Several CAR-T therapies are now approved for blood cancers.

Gene therapy

Treating disease by introducing, altering, or replacing genetic material within a patient's cells. The first CRISPR-based gene therapy (Casgevy) was approved in 2023 for sickle cell disease and beta-thalassemia.

Synthetic biology

The design and construction of new biological parts, devices, and systems – or the redesign of existing ones. Synthetic biology aims to make biology easier to engineer, enabling custom organisms that produce drugs, fuels, or materials.

Bioinformatics

The use of computational tools to analyse biological data – especially DNA sequences, protein structures, and gene expression patterns. Essential for making sense of the massive datasets generated by modern genomics.

Genomics

The study of entire genomes – all the DNA in an organism. Advances in genomics have enabled personalised medicine, where treatments are tailored to an individual's genetic profile.

Proteomics

The large-scale study of proteins – their structures, functions, and interactions. AlphaFold (DeepMind) has predicted the 3D structure of virtually every known protein, a major breakthrough for drug discovery.

Protein folding

Proteins fold into specific 3D shapes that determine their function. Misfolded proteins cause diseases like Alzheimer's and Parkinson's. AI tools like AlphaFold have largely solved the protein structure prediction problem.

Drug discovery

The process of identifying and developing new medicines. Traditionally takes 10-15 years and costs $1-2 billion per drug. AI and biotech tools are aiming to compress timelines and reduce costs dramatically.

Clinical trials

The phased testing of new treatments in humans: Phase I (safety, small group), Phase II (efficacy, larger group), Phase III (large-scale comparison with existing treatments). Only ~10% of drugs entering Phase I eventually reach patients.

Biomarker

A measurable biological indicator – a molecule, gene, or characteristic – that signals normal or diseased processes. Biomarkers enable earlier diagnosis, better patient selection for clinical trials, and personalised treatment decisions.

GMO (genetically modified organism)

An organism whose DNA has been altered using genetic engineering. GMO crops (resistant to pests or drought) are widespread in agriculture. Newer gene-editing techniques like CRISPR offer more precise modifications than earlier GMO methods.

Microbiome

The community of trillions of microorganisms living in and on the human body (especially the gut). Research is revealing links between the microbiome and conditions from obesity to depression, opening new therapeutic avenues.

Biologics

Medicines made from living cells or organisms, as opposed to traditional chemical drugs. Includes monoclonal antibodies, vaccines, cell therapies, and gene therapies. Biologics are the fastest-growing segment of the pharmaceutical market.

Biosimilar

A biological medicine highly similar to an already approved biologic (like a generic for biologics). Biosimilars increase competition and reduce costs, but are more complex to manufacture than generic chemical drugs.

Explore Biotech Content

Read our latest analysis and reporting on biotechnology:

Biotech Blog

Articles on biotech breakthroughs, drug development & analysis